These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 31571524)

  • 1. CXCR4-targeted PET imaging using
    Muz B; Bandara N; Mpoy C; Sun J; Alhallak K; Azab F; Rogers BE; Azab AK
    Cancer Biol Ther; 2020; 21(1):52-60. PubMed ID: 31571524
    [No Abstract]   [Full Text] [Related]  

  • 2.
    Burke BP; Miranda CS; Lee RE; Renard I; Nigam S; Clemente GS; D'Huys T; Ruest T; Domarkas J; Thompson JA; Hubin TJ; Schols D; Cawthorne CJ; Archibald SJ
    J Nucl Med; 2020 Jan; 61(1):123-128. PubMed ID: 31201250
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Luo Y; Cao X; Pan Q; Li J; Feng J; Li F
    J Nucl Med; 2019 Dec; 60(12):1724-1729. PubMed ID: 31101745
    [No Abstract]   [Full Text] [Related]  

  • 4. Hypoxia promotes dissemination and colonization in new bone marrow niches in Waldenström macroglobulinemia.
    Muz B; de la Puente P; Azab F; Ghobrial IM; Azab AK
    Mol Cancer Res; 2015 Feb; 13(2):263-72. PubMed ID: 25232031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positron emission tomography imaging of tumors expressing the human chemokine receptor CXCR4 in mice with the use of 64Cu-AMD3100.
    Weiss ID; Jacobson O; Kiesewetter DO; Jacobus JP; Szajek LP; Chen X; Farber JM
    Mol Imaging Biol; 2012 Feb; 14(1):106-14. PubMed ID: 21347799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 64Cu-AMD3100--a novel imaging agent for targeting chemokine receptor CXCR4.
    Jacobson O; Weiss ID; Szajek L; Farber JM; Kiesewetter DO
    Bioorg Med Chem; 2009 Feb; 17(4):1486-93. PubMed ID: 19188071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SDF-1/CXCR4 and VLA-4 interaction regulates homing in Waldenstrom macroglobulinemia.
    Ngo HT; Leleu X; Lee J; Jia X; Melhem M; Runnels J; Moreau AS; Burwick N; Azab AK; Roccaro A; Azab F; Sacco A; Farag M; Sackstein R; Ghobrial IM
    Blood; 2008 Jul; 112(1):150-8. PubMed ID: 18448868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemokine Receptor CXCR4-Targeted PET/CT With 68Ga-Pentixafor Shows Superiority to 18F-FDG in a Patient With Waldenström Macroglobulinemia.
    Luo Y; Pan Q; Feng J; Cao X; Li F
    Clin Nucl Med; 2018 Jul; 43(7):548-550. PubMed ID: 29742593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical Evaluation of [
    Peng T; Wang X; Li Z; Bi L; Gao J; Yang M; Wang Y; Yao X; Shan H; Jin H
    Mol Pharm; 2021 Sep; 18(9):3638-3648. PubMed ID: 34424706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C1013G/CXCR4 acts as a driver mutation of tumor progression and modulator of drug resistance in lymphoplasmacytic lymphoma.
    Roccaro AM; Sacco A; Jimenez C; Maiso P; Moschetta M; Mishima Y; Aljawai Y; Sahin I; Kuhne M; Cardarelli P; Cohen L; San Miguel JF; Garcia-Sanz R; Ghobrial IM
    Blood; 2014 Jun; 123(26):4120-31. PubMed ID: 24711662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of N-[(11)C]methyl-AMD3465 as a PET tracer for imaging of CXCR4 receptor expression in a C6 glioma tumor model.
    Hartimath SV; van Waarde A; Dierckx RA; de Vries EF
    Mol Pharm; 2014 Nov; 11(11):3810-7. PubMed ID: 25094028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathway and mechanism of drug binding to chemokine receptors revealed by accelerated molecular simulations.
    Pawnikar S; Miao Y
    Future Med Chem; 2020 Jul; 12(13):1213-1225. PubMed ID: 32515227
    [No Abstract]   [Full Text] [Related]  

  • 13. Bridged cyclams as imaging agents for chemokine receptor 4 (CXCR4).
    Woodard LE; De Silva RA; Behnam Azad B; Lisok A; Pullambhatla M; G Lesniak W; Mease RC; Pomper MG; Nimmagadda S
    Nucl Med Biol; 2014 Aug; 41(7):552-61. PubMed ID: 25038987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo validation of
    Renard I; Domarkas J; Poty S; Burke BP; Roberts DP; Goze C; Denat F; Cawthorne CJ; Archibald SJ
    Nucl Med Biol; 2023; 120-121():108335. PubMed ID: 37068392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Waldenström's macroglobulinemia].
    Watanabe R
    Rinsho Ketsueki; 2015 Oct; 56(10):2074-85. PubMed ID: 26458447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemokine Receptor 4-Targeted 68Ga-Pentixafor PET/CT in Response Assessment of Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma: Comparison to 18F-FDG PET/CT.
    Pan Q; Cao X; Luo Y; Li J; Li F
    Clin Nucl Med; 2021 Sep; 46(9):732-737. PubMed ID: 34172595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxic drugs in combination with the CXCR4 antagonist AMD3100 as a potential treatment option for pediatric rhabdomyosarcoma.
    Regenbogen S; Stagno MJ; Schleicher S; Schilbach K; Bösmüller H; Fuchs J; Schmid E; Seitz G
    Int J Oncol; 2020 Jul; 57(1):289-300. PubMed ID: 32377699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of the MYD88
    Wu YY; Jia MN; Cai H; Qiu Y; Zhou DB; Li J; Cao XX
    Ann Hematol; 2020 Aug; 99(8):1763-1769. PubMed ID: 32577844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual NAMPT and BTK Targeting Leads to Synergistic Killing of Waldenström Macroglobulinemia Cells Regardless of MYD88 and CXCR4 Somatic Mutation Status.
    Cea M; Cagnetta A; Acharya C; Acharya P; Tai YT; Yang C; Lovera D; Soncini D; Miglino M; Fraternali-Orcioni G; Mastracci L; Nencioni A; Montecucco F; Monacelli F; Ballestrero A; Hideshima T; Chauhan D; Gobbi M; Lemoli RM; Munshi N; Treon SP; Anderson KC
    Clin Cancer Res; 2016 Dec; 22(24):6099-6109. PubMed ID: 27287071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [⁹⁹mTc]O₂-AMD3100 as a SPECT tracer for CXCR4 receptor imaging.
    Hartimath SV; Domanska UM; Walenkamp AM; Rudi A J O D; de Vries EF
    Nucl Med Biol; 2013 May; 40(4):507-17. PubMed ID: 23522974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.